Terapie SARS-Cov-2 | Clorochina e idrossiclorochina
In rosso le review, in verde gli RCT.
- > New England Journal of Medicine, 8 ottobre 2020 | “Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19”
- New England Journal of Medicine, 6 agosto 2020 | “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19”
- Annals of Internal Medicine, 16 luglio 2020 | “Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19”
- Annals of Internal Medicine (editoriale) : “The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale”
- Associazione Alessandro Liberati – Network Italiano Cochrane, 15 maggio 2020 | Idrossiclorochina in pazienti ospedalizzati con COVID lieve-moderata: RCT in aperto
- Science, 9 giugno 2020
Link: Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19 - quotidianosanità.it, 3 giugno 2020
Link: Covid. Idrossiclorochina. Oms riavvia sperimentazione: “Non ci sono evidenze su dati mortalità che giustifichino modifiche al protocollo originale del trial” - New England Journal of Medicine, 3 giugno 2020
Link: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 - New England Journal of Medicine, Editoriale, 3 giugno 2020
Link: Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence - AIFA, 26 maggio 2020
Link: AIFA sospende l’autorizzazione all’utilizzo di idrossiclorochina per il trattamento del COVID-19 al di fuori degli studi clinici - The Lancet, 22 maggio 2020
Link: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analys
AGGIORNAMENTO 4 giugno 2020: Retraction – Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis - BMJ, 14 maggio 2020
Link: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial - JAMA, 11 maggio 2020
Link: Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State - Istituto Mario Negri, 8 maggio 2020
Link: COVID-10 e clorochina: non provata l’efficacia all’inizio di malattia” - New England Journal of Medicine, 7 maggio
Link: Editoriale The Urgency of Care during the Covid-19 Pandemic – Learning as We Go - New England Journal of Medicine, 7 maggio 2020
Link: Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 - Open Forum Infectious Diseases, 6 maggio 2020
Link: Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) - Lancet Infect Dis, 29 aprile 2020 [richiamo articolo novembre 2003]
Link: Effects of chloroquine on viral infections: an old drug against today’s diseases - AIFA, update 29 aprile 2020
Link: Idrossiclorochina nella terapia dei pazienti adulti con COVID-19 - The FASEB Journal, 29 aprile 2020
Link: Review “Rethinking the role of Hydroxychloroquine in the treatment of COVID-19